Iterum Therapeutics Plc
(NASDAQ) ITRM
Iterum Therapeutics Plc Financials at a Glance
Market Cap
$1.59M
Revenue (TTM)
$390.00K
Net Income (TTM)
$26.96M
EPS (TTM)
$-0.75
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$0.05
Volume
10,412,116
Open
$0.03
Price
$0.05
Volume
10,412,116
Open
$0.03
Previous Close
$0.05
Daily Range
$0.02 - $0.05
52-Week Range
$0.02 - $1.42
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$0.05
Volume
10,412,116
Open
$0.03
Previous Close
$0.05
Daily Range
$0.02 - $0.05
52-Week Range
$0.02 - $1.42
ITRM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Iterum Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
9
CEO
Corey N. Fishman
Website
www.iterumtx.comHeadquarters
Dublin, 2, IE
ITRM Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-52%
Net Income Margin
-69%
Return on Equity
0%
Return on Capital
-78%
Return on Assets
-83%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.59M
Shares Outstanding
52.84M
Volume
10.41M
Short Interest
0.00%
Avg. Volume
16.35M
Financials (TTM)
Gross Profit
$254.00K
Operating Income
$18.70M
EBITDA
$21.73M
Operating Cash Flow
$26.77M
Capital Expenditure
$2.00K
Free Cash Flow
$26.77M
Cash & ST Invst.
$24.13M
Total Debt
$45.53M
Iterum Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$390.00K
N/A
Gross Profit
$370.00K
N/A
Gross Margin
94.87%
N/A
Market Cap
$1.59M
N/A
Market Cap/Employee
$176.12K
N/A
Employees
9
N/A
Net Income
$8.98M
-47.3%
EBITDA
$8.05M
-50.2%
Quarterly Fundamentals
Net Cash
$22.73M
-186.5%
Accounts Receivable
$546.00K
N/A
Inventory
$1.15M
N/A
Long Term Debt
$33.45M
+283.3%
Short Term Debt
$281.00K
-98.0%
Return on Assets
-82.95%
N/A
Return on Invested Capital
-77.82%
N/A
Free Cash Flow
$7.86M
-194.2%
Operating Cash Flow
$7.85M
-193.7%